New drug aims to boost height in kids with dwarfism
NCT ID NCT07441876
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This study tests a new medicine called BMN 333 against an existing drug (vosoritide) to see if it can safely improve growth in children with achondroplasia, the most common form of dwarfism. About 160 children aged 2 to 17 will take part. The goal is to measure how much they grow over a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACHONDROPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Ann & Robert H. Lurie Children's Hospital of Chicago
RECRUITINGChicago, Illinois, 60611, United States
-
Children's Hospital of Philadelphia
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Cincinnati Children's Hospital Medical Center
NOT_YET_RECRUITINGCincinnati, Ohio, 45229, United States
-
Consano Clinical Research, LLC
RECRUITINGSan Antonio, Texas, 78231, United States
-
Craiova Emergency Clinical County
NOT_YET_RECRUITINGCraiova, 200642, Romania
-
Institutul National de Endocrinologie C.I.Parhon
NOT_YET_RECRUITINGBucharest, Romania
-
Irccs Ospedale Gaslini Di Genova
NOT_YET_RECRUITINGGenova, 16147, Italy
-
Johns Hopkins Medicine
RECRUITINGBaltimore, Maryland, 21205, United States
-
Murdoch Children's Research Institute
RECRUITINGParkville, Victoria, 3052, Australia
-
Nemours Children's Health
NOT_YET_RECRUITINGWilmington, Delaware, 19803, United States
-
Osaka City General Hospital
RECRUITINGOsaka, 534-0021, Japan
-
Pusan National University Yangsan Hospital
NOT_YET_RECRUITINGYangsan, 50612, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, South Korea
-
Texas Children Hospital, Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
-
UCSF Benioff Children's Hospital Oakland
RECRUITINGOakland, California, 94609, United States
-
Universite de Montreal - Centre Hospitalier Universitaire Sainte-Justine
NOT_YET_RECRUITINGMontreal, Quebec, H3T 1C5, Canada
-
University Hospitals Bristol NHS Foundation Trust - Bristol Royal Hospital for Children
NOT_YET_RECRUITINGBristol, United Kingdom
-
University of Texas Southwestern Medical Center
NOT_YET_RECRUITINGDallas, Texas, 75207, United States
-
Uniwersytecki Szpital Kliniczny im. J. Mikulicza-Radeckiego we Wroclawiu Klinika Pediatrii i Chorob Infekcyjnych
NOT_YET_RECRUITINGWroclaw, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a weekly shot help children with achondroplasia grow taller?
- Can growth hormone boost height in children with dwarfism?
- Weekly shot may boost growth in kids with dwarfism
- Experimental achondroplasia drug trial halted early
- No treatment, just tracking: PROPEL study watches how kids with achondroplasia grow
- New registry aims to unlock secrets of bone disorder